Variable | Genotype | OR (95% CI) | P-value | |
CC N (%) | GG (%) | |||
NAFLD patients | 87 (60%) | 58 (40%) | 1.92 (0.742–1.917) | 0.468 |
Control subjects | 93 (64.1%) | 52 (35.9%) | ||
Alleles | OR (95% CI) | P-value | ||
C N (%) | G N (%) | |||
NAFLD patients | 174 (80%) | 116 (20%) | 1.192 (0.852–1.668) | 0.304 |
Control subjects | 186 (82%) | 104 (18%) |